Site icon Syngene International Ltd

Comprehensive preclinical evaluation of bile acid modulators for paediatric liver disease

Learn how Syngene executed complex preclinical studies, consolidating data across pharmacokinetics, biomarker modulation, and gene expression analysis, and provided comprehensive insights for the client’s development decision on bile acid modulators for paediatric liver disease.

Exit mobile version